This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

2 big 30,000 50,000 buys through.

edited out.

someone else game playing.................

I see, ok likewise.
Many thanks

Chiva

Eased off a bit lately but we should see more blue as this one usually rallies later on in the day.

Im still rather cautious on this one. Going to watch how it goes for a couple of days.

cheers GF.

ARE YOU TALKING LONG TERM OR SHORT TERM GOLDFINGER.

?cautious GF?

Short term. Ive still got my long term stock which I purchased at between 40p and 80p. Im wanting though to add but still dont feel confident enough with no news due for about 20 days. In the meantime Evil will be throwing everything at it bar the kitchen sink even if he is being questioned by the powder puff FSA.

cheers GF.

I took the bull by the horns and topped up at 171. In my view we will see 3 again and fairly soon so I just went for it. MMG has too much going for it although I think the shorters still have it. But to quote a well know saying "I'll be back"

MS

Goodnews Guys lifted from another board refering to Evils position evil says...

"All these unpleasant losses and margin calls have prompted me to bank a few gains in Medical Marketing (MMG) at 182p. It is my intention to run a short position as the latest Waanders note and 40p target price is compelling stuff. But given that Medical is fighting hard I see no problem in taking a few coppers off the table" ENDS.

looks like hes beginning to realise theres good news not far off.

Still watching for a few days.

cheers GF.

Great news! I see it as risky, but you got to be innit to winnit, innit?

Things are looking up, well done GF. 3 here we come.

MS

If EK was certain that MMG is so overvalued then why did he close some of his short this AM?. Any sign that he is loosing control and he will be out like a flash.

,,,or maybe he wants to appease the FSA !!!

B

It has been reported that Garry Waanders has resigned.

I'm starting to feel good again. Don't you just feel sorry for Garry.

MS

That is the best news i`ve heard in a long time,he was obviously a total plonker!!!!
db66

If the analyst as resigned its a massive kick in the teeth for Evil K and his buddies. Can anyone confirm where the news comes from????????????.

Ill be back in if this is correct as it should give the stock a massive boost.


cheers GF.

Looks like a recovery this afternoon as i said.

From the other place. A good read. The guys that post on the MMG thread are good and sensible, unlike most of them.

Remember this is not a one product company. Genvax is only the first of MMG's investments to enter phase II clinical trials. And it is only one subsidiary. Let's not lose sight of that fact. Another is Oncosense and its technology based around the precious metal ruthenium. I believe three ruthenium compounds could be going to clinic this year. The prospects for these seem to be absolutely massive.

http://www.platinum.matthey.com/media_room/1107165603.html
Ruthenium cancer treatment proves effective - 31st January 2005

David Best (executive chairman), said the performance of the pgm-based treatment had been verified by independent laboratory tests undertaken by CXR Biosciences, stressing both the safety and the efficacy of the drug.

He explained: "Ruthenium is only one of MMI's portfolio of excellent drug candidates, but already data show it to be potentially the most effective drug against serious cancers like lung, colon and ovarian.

"This new data from CXR shows ruthenium to be potentially relatively safe too. If these results are confirmed in the clinical trials, then ruthenium may improve significantly on the standard treatment for cancer patients and become a major commercial success in a cancer therapy market that was worth $42 billion in 2004 and continues to grow in double-digit figures."

That last sentence is well worth reading again.

And then there are the other subsidiaries of MMG: Viratis and Endozyme, each with potential blockbusters of their own. There is a real chance that these could lead to not one but SEVERAL deals and each one could be worth a multiple of the current market cap of the whole company.

MMG is now capitalised at around 80m. By the end of this year they could have eight drugs in Phase II clinical trials. Success in any one of these will bring big Pharma stepping in for a piece of the action. It's well known that licenses can be worth anything upwards of 100m and have been known to be worth as much as 2bn. But we don't have a precedent for cancer cures yet, these would surely be worth even more.

What value the market cap then??

Institutions were buying in at prices well above 2. They, together with the directors hold the vast majority of shares in the company. I don't believe they will be scared out of them by EK and his like. In fact all the shares sold by small punters recently appear to have been mopped up as well. Just one piece of good news from the company or even a couple of decent brokers notes will send the bears scrambling to cover their shorts. When that will happen is anyone's guess but imo long term holders will be well rewarded.

I hold MMG.

MS